S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
How major US stock indexes fared Thursday, 3/28/2024
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
How major US stock indexes fared Thursday, 3/28/2024
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
How major US stock indexes fared Thursday, 3/28/2024
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Asian shares are mostly higher after another set of Wall St records
Foot Locker Builds Up Another Head of Steam; Gains Imminent
Average long-term US mortgage rate falls slightly, easing borrowing costs for home shoppers
Walgreens books hefty charge as the drugstore chain adjusts the value of struggling clinics
Algeria's government pushes staples to subsidized markets to stave off Ramadan shortages
How major US stock indexes fared Thursday, 3/28/2024
OTCMKTS:MRMD

MariMed (MRMD) Stock Price, News & Analysis

$0.26
-0.01 (-3.08%)
(As of 03/28/2024 ET)
Today's Range
$0.26
$0.29
50-Day Range
$0.20
$0.38
52-Week Range
$0.20
$0.55
Volume
369,441 shs
Average Volume
615,865 shs
Market Capitalization
$99.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MRMD stock logo

About MariMed Stock (OTCMKTS:MRMD)

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

MRMD Stock Price History

MRMD Stock News Headlines

4x Better than Bitcoin
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
4x Better than Bitcoin
4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.
MariMed's Earnings: A Preview
MariMed Closes $58.7 Million Debt Refinancing
See More Headlines
Receive MRMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/15/2021
Today
3/29/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
N/A
Current Symbol
OTCMKTS:MRMD
Fax
N/A
Employees
643
Year Founded
N/A

Profitability

Net Income
$-16,030,000.00
Pretax Margin
-4.44%

Debt

Sales & Book Value

Annual Sales
$148.60 million
Cash Flow
$0.03 per share
Book Value
$0.19 per share

Miscellaneous

Free Float
298,041,000
Market Cap
$99.06 million
Optionable
Not Optionable
Beta
2.85
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Jon R. Levine (Age 59)
    Co-Founder, CEO, Interim CFO, President, Secretary, Treasurer & Director
    Comp: $481.74k
  • Mr. Timothy Shaw (Age 46)
    Chief Operating Officer
    Comp: $445.86k
  • Mr. Jonathan W. Rider (Age 59)
    Chief Information Officer
  • Mr. Steve Wayne West
    Vice President of Investor Relations
  • Mr. Howard Schacter
    Chief Communications Officer
  • Ms. Sara Gullickson (Age 39)
    Vice President of Marketing
  • Mr. Ryan Crandall
    Chief Revenue Officer
  • Mr. Charles Holt Finnie
    Chief Strategy Officer

MRMD Stock Analysis - Frequently Asked Questions

How have MRMD shares performed in 2024?

MariMed's stock was trading at $0.2748 at the start of the year. Since then, MRMD stock has decreased by 3.9% and is now trading at $0.2641.
View the best growth stocks for 2024 here
.

Are investors shorting MariMed?

MariMed saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 53,200 shares, an increase of 198.9% from the February 29th total of 17,800 shares. Based on an average trading volume of 1,346,700 shares, the days-to-cover ratio is presently 0.0 days.
View MariMed's Short Interest
.

How were MariMed's earnings last quarter?

MariMed Inc. (OTCMKTS:MRMD) issued its quarterly earnings data on Monday, November, 15th. The company reported $0.01 EPS for the quarter. The company earned $33.21 million during the quarter. MariMed had a negative net margin of 10.79% and a negative trailing twelve-month return on equity of 1.84%.

What guidance has MariMed issued on next quarter's earnings?

MariMed issued an update on its FY 2024 earnings guidance on Wednesday, March, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $156.0 million-$159.0 million, compared to the consensus revenue estimate of $173.8 million.

What other stocks do shareholders of MariMed own?
How do I buy shares of MariMed?

Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:MRMD) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners